Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Viva Biotech Holdings

Market Cap: HK$3.4b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

Zevra Therapeutics

Market Cap: US$423.8m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Oxford Biomedica

Market Cap: UK£309.5m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Handa Pharmaceuticals

Market Cap: NT$12.4b

A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China.

Prothena

Market Cap: US$409.6m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Amylyx Pharmaceuticals

Market Cap: US$407.6m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Zenas BioPharma

Market Cap: US$407.5m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

Tourmaline Bio

Market Cap: US$405.4m

Operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases.

Celcuity

Market Cap: US$403.9m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Precigen

Market Cap: US$402.8m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

EyePoint Pharmaceuticals

Market Cap: US$402.5m

Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.

JCR Pharmaceuticals

Market Cap: JP¥59.1b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

REGENXBIO

Market Cap: US$399.8m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Mereo BioPharma Group

Market Cap: US$397.5m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Erasca

Market Cap: US$393.7m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥57.8b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Myriad Genetics

Market Cap: US$391.8m

A molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.

ABIVAX Société Anonyme

Market Cap: €348.8m

A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

PureTech Health

Market Cap: UK£292.1m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Verve Therapeutics

Market Cap: US$387.8m

A clinical-stage company, develops gene editing medicines for patients to treat cardiovascular disease in the United States.

Tectonic Therapeutic

Market Cap: US$386.5m

A clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein-coupled receptors (GPCRs).

ORIC Pharmaceuticals

Market Cap: US$384.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Cytek Biosciences

Market Cap: US$382.5m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Rapport Therapeutics

Market Cap: US$382.1m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Organogenesis Holdings

Market Cap: US$378.7m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Alpha Teknova

Market Cap: US$377.3m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Verastem

Market Cap: US$375.4m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Absci

Market Cap: US$373.7m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

MBX Biosciences

Market Cap: US$372.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Oruka Therapeutics

Market Cap: US$365.0m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Faron Pharmaceuticals Oy

Market Cap: UK£274.2m

Operates as a clinical stage drug discovery and development company.

COMPASS Pathways

Market Cap: US$363.0m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

JW Pharmaceutical

Market Cap: ₩509.5b

Manufactures and sells medicines and medical supplies in Japan and internationally.

Autolus Therapeutics

Market Cap: US$359.3m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$555.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Cryoport

Market Cap: US$358.5m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.